Skip to content
Nonprofiteer
← ALLOSOURCE

Form 990 for tax year 2023

Filed by ALLOSOURCE.

Totals

Total revenue
$172,749,079
Total expenses
$173,901,699
Contributions and grants received
$790,852
Grants paid
$346,328
Program service revenue
$172,567,159
Investment income
-$1,128,677
Other revenue
$519,745
Total assets, end of year
$152,171,181
Total liabilities, end of year
$55,800,798
Net assets or fund balances, end of year
$96,370,383
Program services expenses (Part IX)
$161,404,361
Management and general expenses
$12,497,338
Fundraising expenses
$0
Program service expenses (Part III)
$161,404,361

Program services were 92.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $790,852

  • 2a · Program service revenue: TISSUE DISTRIBUTION & PROCESSING

    total $172,567,159 · related or exempt $172,567,159

  • 2f · All other program service revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 3 · Investment income

    total $333,089 · excluded $333,089

  • 6b · Less rental expenses

    real property $0

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 7a · Gross sales of assets other than inventory

    securities -$1,047,100 · other assets -$414,666

  • 7c · Gain or loss

    securities -$1,047,100 · other assets -$414,666

  • 7d · Net gain or loss

    total -$1,461,766 · excluded -$1,461,766

  • 11a · Other revenue: INCOME (LOSS) FROM JRF

    total $519,745 · related or exempt $519,745

  • 11d · All other revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 11e · Other revenue, total

    $519,745

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $346,328 · program services $346,328

  • 5 · Compensation of officers, directors and key employees

    total $4,533,669 · program services $3,591,100 · management and general $942,569

  • 7 · Other salaries and wages

    total $43,455,292 · program services $37,521,490 · management and general $5,933,802

  • 8 · Pension plan contributions

    total $731,696 · program services $613,504 · management and general $118,192

  • 9 · Other employee benefits

    total $5,133,592 · program services $4,387,613 · management and general $745,979

  • 10 · Payroll taxes

    total $3,560,717 · program services $3,077,218 · management and general $483,499

  • 11b · Fees: legal

    total $728,820 · program services $364,410 · management and general $364,410

  • 11c · Fees: accounting

    total $944,229 · management and general $944,229

  • 11d · Fees: lobbying

    total $12,694 · program services $9,521 · management and general $3,173

  • 11g · Fees: other

    total $1,312,262 · program services $1,085,373 · management and general $226,889 · fundraising $0

  • 12 · Advertising and promotion

    total $310,150 · management and general $310,150

  • 13 · Office expenses

    total $1,406,001 · program services $1,076,595 · management and general $329,406

  • 14 · Information technology

    total $1,452,822 · program services $1,083,034 · management and general $369,788

  • 15 · Royalties

    total $1,142,909 · program services $1,142,909

  • 16 · Occupancy

    total $1,852,958 · program services $1,432,233 · management and general $420,725

  • 17 · Travel

    total $894,483 · program services $827,815 · management and general $66,668

  • 19 · Conferences, conventions and meetings

    total $331,958 · program services $119,458 · management and general $212,500

  • 20 · Interest

    total $872,708 · program services $785,437 · management and general $87,271

  • 22 · Depreciation, depletion and amortization

    total $4,053,210 · program services $3,912,636 · management and general $140,574

  • 23 · Insurance

    total $656,379 · program services $492,284 · management and general $164,095

  • 24a · Other expenses: TISSUE PROCESSING COSTS

    total $85,804,419 · program services $85,804,419

  • 24b · Other expenses: COST OF DISTRIBUTION

    total $8,924,117 · program services $8,924,117

  • 24c · Other expenses: REPAIRS & MAINTENANCE

    total $2,838,943 · program services $2,720,279 · management and general $118,664

  • 24d · Other expenses: LICENSE FEES

    total $1,480,312 · program services $1,327,877 · management and general $152,435

  • 24e · All other expenses

    total $1,121,031 · program services $758,711 · management and general $362,320 · fundraising $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $54,427 · end of year $191,135

  • 2 · Savings and temporary cash investments

    beginning of year $11,492,170 · end of year $12,484,940

  • 3 · Pledges and grants receivable

    beginning of year $0 · end of year $0

  • 4 · Accounts receivable

    beginning of year $21,397,355 · end of year $22,465,805

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $0 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $72,627,339 · end of year $69,541,032

  • 9 · Prepaid expenses and deferred charges

    beginning of year $652,621 · end of year $775,264

  • 10a · Land, buildings and equipment: cost or other basis

    $81,102,870

  • 10b · Land, buildings and equipment: accumulated depreciation

    $45,903,736

  • 10c · Land, buildings and equipment, net

    beginning of year $34,291,529 · end of year $35,199,134

  • 11 · Investments: publicly traded securities

    beginning of year $0 · end of year $0

  • 12 · Investments: other securities

    beginning of year $3,618,652 · end of year $3,618,652

  • 13 · Investments: program-related

    beginning of year $4,726,657 · end of year $5,246,402

  • 14 · Intangible assets

    beginning of year $23,974 · end of year $10,897

  • 15 · Other assets

    beginning of year $2,580,528 · end of year $2,637,920

  • 17 · Accounts payable and accrued expenses

    beginning of year $34,856,710 · end of year $34,412,671

  • 18 · Grants payable

    beginning of year $0 · end of year $0

  • 19 · Deferred revenue

    beginning of year $0 · end of year $0

  • 20 · Tax-exempt bond liabilities

    beginning of year $13,590,659 · end of year $11,630,574

  • 21 · Escrow or custodial account liability

    beginning of year $0 · end of year $0

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $5,290,727 · end of year $7,951,414

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $0

  • 25 · Other liabilities

    beginning of year $1,959,587 · end of year $1,806,139

  • 27 · Net assets without donor restrictions

    beginning of year $95,767,569 · end of year $96,370,383

  • 28 · Net assets with donor restrictions

    beginning of year $0 · end of year $0

  • 29 · Capital stock, trust principal or current funds

    beginning of year $0 · end of year $0

  • 30 · Paid-in or capital surplus, or land, building or equipment fund

    beginning of year $0 · end of year $0

  • 31 · Retained earnings, endowment or other funds

    beginning of year $0 · end of year $0

Mission and programs · 2023

Mission

INSPIRED BY THE GIFT OF DONATION FROM OUR COMMUNITIES, ALLOSOURCE RESPONSIBLY PROVIDES INNOVATIVE CELLULAR AND TISSUE ALLOGRAFTS TO ADVANCE PATIENT HEALING.

Activities or mission (Part I)

ALLOSOURCE RESPONSIBLY PROCESSES AND DISTRIBUTES HUMAN DONATED TISSUE THAT ENHANCES AND SAVES LIVES.

  • PROCESSING AND DISTRIBUTION: WITH THE GIFT OF DONATED TISSUE, ALLOSOURCE PROVIDES INNOVATIVE CELLULAR AND TISSUE ALLOGRAFTS TO ADVANCE PATIENT HEALING. IN 2023, ALLOSOURCE FULFILLED THIS RESPONSIBILITY BY PROCESSING MORE THAN 8,300 DONORS, AND DISTRIBUTED THE TISSUE THROUGHOUT NORTH AMERICA, SOUTH AMERICA, CARIBBEAN, EUROPE, MIDDLE EAST, ASIA AND OCEANIA. MUSCULOSKELETAL AND SOFT TISSUE DONORS PROVIDE AN OPPORTUNITY TO CREATE LIFE-SAVING AND LIFE-ENHANCING SOLUTIONS IN ORTHOPEDIC, SPINE, BURN, AND WOUND PROCEDURES TO HELP RESTORE PATIENT HEALTH AND MOBILITY. ALLOSOURCE IS ACCREDITED BY THE AMERICAN ASSOCIATION OF TISSUE BANKS AND IS REGISTERED WITH THE FDA.

    Expenses $153,558,579 · Revenue $173,086,904

  • RESEARCH, EDUCATION, AND TRAINING: ALLOSOURCE IS DEDICATED TO ADVANCING THE USE OF TRANSPLANTABLE ALLOGENEIC CELLS AND TISSUE THROUGH PIONEERING RESEARCH. IN 2023, ALLOSOURCE CONTINUED ITS RESEARCH IN THE AREAS OF PEDIATRIC ORTHOPEDICS AND CELLULAR THERAPIES, EXPANDING THE IMPACT OF DONATION BY FINDING ADDITIONAL USES FOR TISSUE. ALLOSOURCE WORKED WITH THE 501(C)(3) ORGANIZATIONS THAT RECOVER TISSUE TO REDUCE TISSUE CONTAMINATION. WE ALSO PROVIDED EDUCATIONAL OPPORTUNITIES TO OUR PARTNER ORGAN PROCUREMENT ORGANIZATIONS TO HELP THEM INCREASE DONATION RATES IN THEIR RESPECTIVE COMMUNITIES.

    Expenses $7,499,454

  • CHARITABLE CONTRIBUTION ACTIVITY: IN ALIGNMENT WITH OUR MISSION, ALLOSOURCE PROVIDED GRANTS TO SUPPORT 501(c)(3) ORGANIZATIONS THAT ARE INVOLVED IN ORGAN, EYE, AND TISSUE DONATION, S.T.E.M. EDUCATION, AS WELL AS PATIENT PHYSICAL AND MENTAL HEALING. IN 2023, ALLOSOURCE GAVE GRANTS TO THREE ORGANIZATIONS TO FURTHER TISSUE DONATION AND TRANSPLANTATION AWARENESS AND PROCESSES, AND MADE CHARITABLE CONTRIBUTIONS TO ELEVEN OTHER 501(C)(3) ORGANIZATIONS THROUGH DIRECT AND MATCHING EMPLOYEE FINANCIAL DONATIONS.

    Expenses $346,328 · Grants $346,328

As filed on the 2023 return.

Listed in Part VII

  • Dean H Elliott

    PRESIDENT, CEO AS OF 1/9/23

    Total calculated
    $564,081
    From this org
    $509,715
    From related orgs
    $0
    Other
    $54,366
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $478,318
    Bonus
    $0
    Other
    $31,397
    Deferred
    $39,349
    Nontaxable benefits
    $15,017
    Filer's total
    $564,081

  • Jennifer Prinz

    BOARD MEMBER - CHAIR

    Total calculated
    $0
    Hours/week
    3

  • Mark Simon

    BOARD MEMBER - VICE CHAIR

    Total calculated
    $0
    Hours/week
    3

  • Suzanne Conrad

    BOARD MEMBER - TREASURER

    Total calculated
    $0
    Hours/week
    3

  • Thomas A Cycyota

    PRESIDENT, CEO UNTIL 1/9/23 STRATEGIC ADVISOR 1/10/23-12/29/23

    Total calculated
    $1,580,400
    From this org
    $1,423,126
    From related orgs
    $0
    Other
    $157,274
    Hours/week
    30

    Schedule J breakdown matched by us

    Base
    $440,404
    Bonus
    $0
    Other
    $982,722
    Deferred
    $145,103
    Nontaxable benefits
    $12,171
    Filer's total
    $1,580,400

  • Dr Harry Wilkins

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    3

  • Kevin Lee

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    3

  • Kevin L Whitten

    CHIEF COMMERCIAL OFFICER

    Total calculated
    $458,579
    From this org
    $401,804
    From related orgs
    $0
    Other
    $56,775
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $265,925
    Bonus
    $134,750
    Other
    $1,129
    Deferred
    $35,321
    Nontaxable benefits
    $21,454
    Filer's total
    $458,579

  • Yan Deng

    CHIEF FINANCIAL OFFICER

    Total calculated
    $489,600
    From this org
    $436,805
    From related orgs
    $0
    Other
    $52,795
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $291,273
    Bonus
    $145,001
    Other
    $531
    Deferred
    $36,322
    Nontaxable benefits
    $16,473
    Filer's total
    $489,600

  • Brian R Bobka

    VP INTERNATIONAL

    Total calculated
    $273,723
    From this org
    $230,004
    From related orgs
    $0
    Other
    $43,719
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $209,914
    Bonus
    $0
    Other
    $20,090
    Deferred
    $27,343
    Nontaxable benefits
    $16,376
    Filer's total
    $273,723

  • Kenneth Hammons

    SVP OPERATIONS

    Total calculated
    $438,093
    From this org
    $396,268
    From related orgs
    $0
    Other
    $41,825
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $268,586
    Bonus
    $125,000
    Other
    $2,682
    Deferred
    $29,785
    Nontaxable benefits
    $12,040
    Filer's total
    $438,093

  • Kimberly Meyer

    SVP QUALITY & PERFORMANCE EXCELLENCE

    Total calculated
    $376,360
    From this org
    $325,993
    From related orgs
    $0
    Other
    $50,367
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $215,723
    Bonus
    $110,000
    Other
    $270
    Deferred
    $28,834
    Nontaxable benefits
    $21,533
    Filer's total
    $376,360

  • Michelle Zeppelin

    SVP HUMAN RESOURCES

    Total calculated
    $352,835
    From this org
    $316,827
    From related orgs
    $0
    Other
    $36,008
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $211,889
    Bonus
    $104,500
    Other
    $438
    Deferred
    $27,392
    Nontaxable benefits
    $8,616
    Filer's total
    $352,835

  • Carolyn Rorick

    SR DIRECTOR PRODUCT DEVELOPMENT INNOVATION & CLINICAL AFFAIRS

    Total calculated
    $346,667
    From this org
    $305,168
    From related orgs
    $0
    Other
    $41,499
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $209,966
    Bonus
    $95,000
    Other
    $202
    Deferred
    $25,580
    Nontaxable benefits
    $15,919
    Filer's total
    $346,667

  • Corey Stone

    EXECUTIVE DIRECTOR ESSENT BIOLOGICS

    Total calculated
    $513,436
    From this org
    $495,339
    From related orgs
    $0
    Other
    $18,097
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $164,089
    Bonus
    $107,500
    Other
    $223,750
    Deferred
    $4,297
    Nontaxable benefits
    $13,800
    Filer's total
    $513,436

  • Hannis W Thompson III

    MEDICAL DIRECTOR

    Total calculated
    $258,452
    From this org
    $234,667
    From related orgs
    $0
    Other
    $23,785
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $233,403
    Bonus
    $0
    Other
    $1,264
    Deferred
    $7,272
    Nontaxable benefits
    $16,513
    Filer's total
    $258,452

  • Inga Gurevich

    ASSOCIATE MEDICAL DIRECTOR

    Total calculated
    $249,419
    From this org
    $226,999
    From related orgs
    $0
    Other
    $22,420
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $225,811
    Bonus
    $0
    Other
    $1,188
    Deferred
    $6,984
    Nontaxable benefits
    $15,436
    Filer's total
    $249,419

  • Matthew Ozment

    REGIONAL ACCOUNTS MANAGER - RECONSTRUCTION

    Total calculated
    $245,662
    From this org
    $223,302
    From related orgs
    $0
    Other
    $22,360
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $129,203
    Bonus
    $0
    Other
    $94,099
    Deferred
    $6,802
    Nontaxable benefits
    $15,558
    Filer's total
    $245,662

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 5a · Pay contingent on this organization's revenues

Answered no

  • 4c · Equity-based compensation arrangement
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Schedule J, Part I, Line 4a Severance or change-of-control payment
Corey Stone received a severance payment of $223,600.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
The Following individuals participated in a supplemental executive retirement plan in 2023 sponsored by AlloSource: Thomas A Cycyota - $ 135,203, Dean Elliot - $36,000, Yan Deng - $29,000, Kevin Whitten - $26,950, Ken Hammons - $25,000, Kimberly Meyer - $22,000, Brian Bobka - $21,238, Carolyn Rorick - $21,000, and Michelle Zeppelin - $20,900. The Dollar amount represents the current year Contribution made by AlloSource on behalf of the individuals to the plan in 2023. This information is included in reportable compensation on the form 990, part VII and Schedule J, part II. The Following individuals also participated in a supplemental executive retirement plan in 2023 sponsored by AlloSource: Tom Cycyota - $334,764, Dean Elliot - $29,796, Brian Bobka - $18,463. The Dollar amount represents the current year Distribution made by the plan to the individuals. This information is included in reportable compensation on the form 990, part VII and Schedule J, part II.
Schedule J, Part I, Line 5a Compensation contingent on revenues of the organization
The Sales department has revenue performance as one of their commission plan components.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • ESSENT BIOLOGICS LLC

    PROCESS & DEVELOP HUMAN TISSUE · DE · income -$3,178,011 · assets $0

    Directly controlled by ALLOSOURCE

Provenance

Return type
form_990
Tax year
2023
Filed
27 October 2024
IRS schema version
2023v5.1
Source object
202443019349300404

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.